JFrog Proves FORTUNE 100 Companies Are Getting IoT-Ready and Increasing Their Focus on Securing the Software Supply Chain
First Annual Software Artifact State of the Union Report Shows 1.3M Container Repos, 67 Percent…
First Annual Software Artifact State of the Union Report Shows 1.3M Container Repos, 67 Percent…
Operated approximately 206,000 owned and colocated ASIC servers Produced 1,527 self-mined bitcoin and 471 bitcoin…
BOSTON, MASSACHUSETTS, Feb. 06, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a…
– The study will evaluate the safety, tolerability and ability of [18F]OP-801 to cross the…
SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
NEW ORLEANS and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo” or the…
BURLINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the…
Abstract, titled “HPV16-specific CD4 and CD8 T cell activation and functionality in patients receiving combination…
BOSTON and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…
MELBOURNE, Australia, Feb. 06, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
NAARDEN, The Netherlands and MIAMI, Feb. 06, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….
NEWARK, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Media Release 20 patients with 1st line non-small cell lung cancer (1L NSCLC) now enrolled…
SANTA MONICA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced…
BIO CEO & Investor Conference 2023 IASLC 2023 Targeted Therapies of Lung Cancer Meeting 16th…
PharmAla Biotech will provide MDMA to Revive Therapeutics in their development of an MDMA Microneedle…
PALO ALTO, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE…